Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer:A Single Arm,Single Center,Phase II Study

NCT03244358 is registered in ClinicalTrials.gov with Sun Yat-sen University as lead sponsor.

NCT NCT03244358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03244358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Epalrestat in Metastatic Triple-negative Breast Cancer:A Single Arm,Single Center,Phase II Study
Lead sponsor
Sun Yat-sen University
Phase
Phase 2
Overall status
Terminated
Start date
March 1, 2017
Completion date
December 1, 2020
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer